MetaCap

Aardvark Therapeutics Insider Trades

NASDAQ: AARDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.9226-0.0774 (-7.74%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
2 · $144.59K
Sales
2 · $394.96K
Shares bought / sold
10.00K / 76.75K
Net activity
Net selling $250,362

Aardvark Therapeutics insider activity

Over the last 12 months, Aardvark Therapeutics insiders reported 4 transactions on SEC Form 4: 2 open-market purchases and 2 sales. Insiders bought $144,595 and sold $394,957 worth of stock, for net insider selling of $250,362. The largest seller was Sun Nelson, with $394,957 in reported sales.

The most recent filing shows Sun Nelson (See Remarks) selling 62,000 shares at $5.18 on Sep 11, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AARD's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

AARD insider transactions

Aardvark Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 11, 2026Sun NelsonSee RemarksSale62,000$321.18KForm 4
Sep 10, 2026Sun NelsonSee RemarksSale14,754$73.78KForm 4
Dec 11, 2025Lee Tien-LiChief Executive OfficerBuy7,000$101.39KForm 4
Dec 11, 2025Sun NelsonChief Financial OfficerBuy3,000$43.20KForm 4
Oct 15, 2025Jones BryanChief Operating OfficerOption exercise1,250$5.30KForm 4
Oct 15, 2025Lee Tien-LiChief Executive OfficerOption exercise1,229$5.21KForm 4
Sep 15, 2025Lee Tien-LiChief Executive OfficerBuy3,500$34.80KForm 4
Sep 15, 2025Lee Tien-LiChief Executive OfficerBuy6,500$61.82KForm 4
Sep 12, 2025Lee Tien-LiChief Executive OfficerBuy5,000$42.52KForm 4
Sep 11, 2025Lee Tien-LiChief Executive OfficerBuy6,000$46.93KForm 4
Sep 10, 2025Lee Tien-LiChief Executive OfficerBuy9,000$71.21KForm 4
Sep 9, 2025Sun NelsonChief Financial OfficerBuy6,000$48.44KForm 4
Aug 28, 2025Lee Tien-LiChief Executive OfficerOption exercise17,209$72.97KForm 4
Feb 14, 2025Cormorant Asset Management, LP & Chen BihuaFormer 10% OwnerBuy187,500$3.00MForm 4
Feb 14, 2025Cormorant Asset Management, LP & Chen BihuaFormer 10% OwnerConversion800,189—Form 4
Feb 14, 2025Sun NelsonChief Financial OfficerBuy10,000$160.00KForm 4
Feb 14, 2025Sun NelsonChief Financial OfficerConversion7,001—Form 4
Feb 14, 2025Lee Tien-LiChief Executive OfficerBuy16,542$264.67KForm 4
Feb 14, 2025Lee Tien-LiChief Executive OfficerConversion41,303—Form 4
Feb 14, 2025Vickers Venture Fund VI Pte Ltd10% OwnerConversion413,491—Form 4
Feb 14, 2025Vickers Venture Fund VI Pte Ltd10% OwnerConversion1,637,411—Form 4
Feb 14, 2025Chi JeffreyDirectorConversion133,364—Form 4
Feb 14, 2025Decheng Capital Global Life Sciences Fund IV, L.P. & Decheng Capital Management IV (Cayman), LLC & Decheng Capital Global Healthcare Fund (Master), LP & Decheng Capital Global Healthcare GP, LLC & Cui Xiangmin10% OwnerBuy625,000$10.00MForm 4
Feb 14, 2025Decheng Capital Global Life Sciences Fund IV, L.P. & Decheng Capital Management IV (Cayman), LLC & Decheng Capital Global Healthcare Fund (Master), LP & Decheng Capital Global Healthcare GP, LLC & Cui Xiangmin10% OwnerBuy625,000$10.00MForm 4
Feb 14, 2025Decheng Capital Global Life Sciences Fund IV, L.P. & Decheng Capital Management IV (Cayman), LLC & Decheng Capital Global Healthcare Fund (Master), LP & Decheng Capital Global Healthcare GP, LLC & Cui Xiangmin10% OwnerConversion333,412—Form 4
Feb 14, 2025Decheng Capital Global Life Sciences Fund IV, L.P. & Decheng Capital Management IV (Cayman), LLC & Decheng Capital Global Healthcare Fund (Master), LP & Decheng Capital Global Healthcare GP, LLC & Cui Xiangmin10% OwnerConversion2,333,887—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related